Although the requirement of neurotrophins for the prevention of cell death in the peripheral nervous system is well established, their physiological involvement in nerve growth is still unclear. To ...
Treatment sequencing in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains a major unmet clinical need ...
Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
Ultrasound and artificial intelligence-guided algae microrobots delivered chemotherapy deep into tumors in mice, paving the way to improved bladder cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results